Expression of myoglobin gene in skeletal muscle of patients with neuromuscular diseases.
Expression of the myoglobin (Mb) gene in skeletal muscle was studied in patients with Duchenne muscular dystrophy (DMD), polymyositis (PM), or amyotrophic lateral sclerosis (ALS) by measuring Mb concentration by radioimmunoassay and Mb messenger ribonucleic acid (RNA) (MbmRNA) levels by Northern blot analysis. Mb concentrations in the muscle cells (Mb/noncollagenous protein) were decreased in patients with DMD, PM, or ALS. However, while Mb concentrations per MbmRNA content (Mb/MbmRNA) were decreased in DMD and PM patients, these values were normal in ALS patients. These results suggest that Mb synthesis is increased in muscles of DMD and PM patients, but is not sufficient to compensate for the excessive loss of Mb from the affected muscles, and that the synthesis is decreased in the muscles of ALS patients.
Kawai
H
H
First Department of Internal Medicine, School of Medicine, University of Tokushima, Japan.
Naruo
T
T
Yoneda
K
K
Masuda
K
K
Mitsui
T
T
Nishida
Y
Y
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D005260:Female; D015870:Gene Expression; D006801:Humans; D008297:Male; D008875:Middle Aged; D009124:Muscle Proteins / Q000378:metabolism; D009132:Muscles / Q000502:physiology*; D009211:Myoglobin / Q000235:genetics* / Q000378:metabolism; D009468:Neuromuscular Diseases / Q000235:genetics*; D012333:RNA, Messenger / Q000378:metabolism
D009124:Muscle Proteins; D009211:Myoglobin; D012333:RNA, Messenger